Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastatic Breast Cancer

Inclusion Criteria:

Documented informed consent of the participant
Age: >= 18 years
Eastern Cooperative Oncology Group (ECOG) =< 2
Ability to read and understand English or Spanish for questionnaires
Documented diagnosis of metastatic breast cancer with at least a 6 month life expectancy
A planned course of taxane based chemotherapy in the metastatic setting, including paclitaxel, docetaxel or abraxane
At least 6 months from the last chemotherapy causing hair loss with complete recovery of hair
Willing to be contacted for brief annual assessments for five years
Women of childbearing potential (WOCBP): negative urine pregnancy test

Agreement by females of childbearing potential to use an effective method of birth control or abstain from heterosexual activity for the course of the study

Childbearing potential defined as not being surgically sterilized (men and women) or have not been free from menses for > 1 year (women only)

Exclusion Criteria:

Autoimmune disease affecting hair; e.g. alopecia areata, systemic lupus with associated hair loss
A history of whole brain radiation with persistent hair thinning or alopecia, or concurrent whole brain radiation therapy
Exposure to other investigational agents, drugs, device or procedure that may cause hair loss
Patients with female pattern baldness resembling picture I-3 or higher on the Savin scale
Any cutaneous scalp metastases
Clinically significant liver dysfunction considered significant as determined by treating physician that would limit the patient's ability to administer the scalp cooling device
Clinically significant renal dysfunction considered significant as determined by treating physician that would limit the patient's ability to administer the scalp cooling device
A history of persistent grade 2 (or higher) alopecia induced by prior chemotherapeutic regimens
Evidence of untreated or poorly controlled hyper or hypothyroidism
American Society of Anesthesiologist Class >= 3
Any other condition that would, in the Investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures
Pregnant or breastfeeding
Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)